bn:23805884n
Noun Named Entity
IT
No term available
EN
Tagraxofusp, sold under the brand name Elzonris, is an anti-cancer medication for the treatment of blastic plasmacytoid dendritic cell neoplasm. Wikipedia
Relations
Sources